These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38288568)

  • 21. One-pot synthesis, characterization and antiviral properties of new benzenesulfonamide-based spirothiazolidinones.
    Apaydın ÇB; Naesens L; Cihan-Üstündağ G
    Mol Divers; 2024 Jun; ():. PubMed ID: 38935302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infections.
    Neyts J; Meerbach A; McKenna P; De Clercq E
    Antiviral Res; 1996 May; 30(2-3):125-32. PubMed ID: 8783804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral activity of benzimidazole derivatives. I. Antiviral activity of 1-substituted-2-[(benzotriazol-1/2-yl)methyl]benzimidazoles.
    Tonelli M; Paglietti G; Boido V; Sparatore F; Marongiu F; Marongiu E; La Colla P; Loddo R
    Chem Biodivers; 2008 Nov; 5(11):2386-401. PubMed ID: 19035566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of NS5 Protein in Determination of Host Cell Range for Yellow Fever Virus.
    Laurent-Rolle M; Morrison J
    DNA Cell Biol; 2019 Dec; 38(12):1414-1417. PubMed ID: 31633391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model.
    Julander JG; Morrey JD; Blatt LM; Shafer K; Sidwell RW
    Antiviral Res; 2007 Feb; 73(2):140-6. PubMed ID: 17049380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two novel fusion inhibitors of human respiratory syncytial virus.
    Lundin A; Bergström T; Bendrioua L; Kann N; Adamiak B; Trybala E
    Antiviral Res; 2010 Dec; 88(3):317-24. PubMed ID: 20965215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiviral activity of hop constituents against a series of DNA and RNA viruses.
    Buckwold VE; Wilson RJ; Nalca A; Beer BB; Voss TG; Turpin JA; Buckheit RW; Wei J; Wenzel-Mathers M; Walton EM; Smith RJ; Pallansch M; Ward P; Wells J; Chuvala L; Sloane S; Paulman R; Russell J; Hartman T; Ptak R
    Antiviral Res; 2004 Jan; 61(1):57-62. PubMed ID: 14670594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rifapentine is an entry and replication inhibitor against yellow fever virus both in vitro and in vivo.
    Qian X; Wu B; Tang H; Luo Z; Xu Z; Ouyang S; Li X; Xie J; Yi Z; Leng Q; Liu Y; Qi Z; Zhao P
    Emerg Microbes Infect; 2022 Dec; 11(1):873-884. PubMed ID: 35249454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and antiviral evaluation of N-carboxamidine-substituted analogues of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine hydrochloride.
    Gabrielsen B; Phelan MJ; Barthel-Rosa L; See C; Huggins JW; Kefauver DF; Monath TP; Ussery MA; Chmurny GN; Schubert EM
    J Med Chem; 1992 Aug; 35(17):3231-8. PubMed ID: 1507208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclopiazonic acid, an inhibitor of calcium-dependent ATPases with antiviral activity against human respiratory syncytial virus.
    Cui R; Wang Y; Wang L; Li G; Lan K; Altmeyer R; Zou G
    Antiviral Res; 2016 Aug; 132():38-45. PubMed ID: 27210812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment of Vero cell lines persistently harboring a yellow fever virus 17D subgenomic replicon.
    Saito K; Shimasaki K; Fukasawa M; Suzuki R; Okemoto-Nakamura Y; Katoh K; Takasaki T; Hanada K
    Virus Res; 2022 Dec; 322():198935. PubMed ID: 36152929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative Infections of Zika, Dengue, and Yellow Fever Viruses in Human Cytotrophoblast-Derived Cells Suggest a Gating Role for the Cytotrophoblast in Zika Virus Placental Invasion.
    Viettri M; Caraballo G; Sanchez ME; Espejel-Nuñez A; Betanzos A; Ortiz-Navarrete V; Estrada-Gutierrez G; Nava P; Ludert JE
    Microbiol Spectr; 2023 Jun; 11(3):e0063023. PubMed ID: 37227282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wild-Type Yellow Fever Virus RNA in Cerebrospinal Fluid of Child.
    Marinho PES; Alvarenga PPM; Crispim APC; Candiani TMS; Alvarenga AM; Bechler IM; Alves PA; Dornas FP; de Oliveira DB; Bentes AA; Christo PP; Kroon EG
    Emerg Infect Dis; 2019 Aug; 25(8):1567-1570. PubMed ID: 31310221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1H-Indole-2,3-dione 3-thiosemicarbazones carrying a 4-sulfamoylphenyl moiety with selective antiviral activity against reovirus-1.
    Göktaş F; Duran GN; Özbil M; Soylu-Eter Ö; Karalı N
    Acta Chim Slov; 2024 Apr; 71(2):215-225. PubMed ID: 38919104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overlapping and distinct molecular determinants dictating the antiviral activities of TRIM56 against flaviviruses and coronavirus.
    Liu B; Li NL; Wang J; Shi PY; Wang T; Miller MA; Li K
    J Virol; 2014 Dec; 88(23):13821-35. PubMed ID: 25253338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies.
    Mishra N; Boudewijns R; Schmid MA; Marques RE; Sharma S; Neyts J; Dallmeier K
    mBio; 2020 Apr; 11(2):. PubMed ID: 32265332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Live-attenuated YF17D-vectored COVID-19 vaccine protects from lethal yellow fever virus infection in mouse and hamster models.
    Ma J; Yakass MB; Jansen S; Malengier-Devlies B; Van Looveren D; Sanchez-Felipe L; Vercruysse T; Weynand B; Javarappa MPA; Quaye O; Matthys P; Roskams T; Neyts J; Thibaut HJ; Dallmeier K
    EBioMedicine; 2022 Sep; 83():104240. PubMed ID: 36041265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice.
    Kum DB; Boudewijns R; Ma J; Mishra N; Schols D; Neyts J; Dallmeier K
    Emerg Microbes Infect; 2020; 9(1):520-533. PubMed ID: 32116148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3',5'Di-O-trityluridine inhibits in vitro flavivirus replication.
    De Burghgraeve T; Selisko B; Kaptein S; Chatelain G; Leyssen P; Debing Y; Jacobs M; Van Aerschot A; Canard B; Neyts J
    Antiviral Res; 2013 May; 98(2):242-7. PubMed ID: 23470860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specialized
    Li D; Lu HT; Ding YZ; Wang HJ; Ye JL; Qin CF; Liu ZY
    J Virol; 2023 Apr; 97(4):e0194922. PubMed ID: 37017533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.